QuidelOrtho Corp (QDEL)
39.55
+0.46
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
39.55
0.00 (0.00%)
After-Hours: 19:06
QuidelOrtho Cash from Operations (Quarterly): -97.90M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -97.90M |
| March 31, 2024 | -0.70M |
| December 31, 2023 | 80.40M |
| September 30, 2023 | 41.50M |
| June 30, 2023 | -30.60M |
| March 31, 2023 | 188.90M |
| December 31, 2022 | 169.40M |
| September 30, 2022 | -9.70M |
| June 30, 2022 | 224.70M |
| March 31, 2022 | 500.90M |
| December 31, 2021 | 321.40M |
| September 30, 2021 | 77.00M |
| June 30, 2021 | -177.96M |
| March 31, 2021 | 585.46M |
| December 31, 2020 | 439.13M |
| September 30, 2020 | 70.46M |
| June 30, 2020 | 59.00M |
| March 31, 2020 | 61.18M |
| December 31, 2019 | 47.72M |
| September 30, 2019 | 13.33M |
| June 30, 2019 | 40.53M |
| March 31, 2019 | 32.90M |
| December 31, 2018 | 43.22M |
| September 30, 2018 | 30.28M |
| June 30, 2018 | 27.03M |
| Date | Value |
|---|---|
| March 31, 2018 | 35.81M |
| December 31, 2017 | 11.22M |
| September 30, 2017 | -7.523M |
| June 30, 2017 | -5.568M |
| March 31, 2017 | 29.58M |
| December 31, 2016 | 16.62M |
| September 30, 2016 | -2.35M |
| June 30, 2016 | 5.141M |
| March 31, 2016 | -7.597M |
| December 31, 2015 | 16.63M |
| September 30, 2015 | -3.01M |
| June 30, 2015 | -8.504M |
| March 31, 2015 | 31.77M |
| December 31, 2014 | 18.21M |
| September 30, 2014 | 0.186M |
| June 30, 2014 | -4.865M |
| March 31, 2014 | 22.16M |
| December 31, 2013 | 1.464M |
| September 30, 2013 | -5.098M |
| June 30, 2013 | -5.129M |
| March 31, 2013 | 34.44M |
| December 31, 2012 | 13.75M |
| September 30, 2012 | 0.702M |
| June 30, 2012 | 1.48M |
| March 31, 2012 | 3.703M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-177.96M
Minimum
Jun 2021
585.46M
Maximum
Mar 2021
134.23M
Average
70.46M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.705B |
| Becton Dickinson & Co | 1.263B |
| Repligen Corp | 42.19M |
| Perspective Therapeutics Inc | -8.902M |
| Xtant Medical Holdings Inc | -5.088M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -35.30M |
| Cash from Financing (Quarterly) | 162.50M |
| Free Cash Flow | -170.10M |
| Free Cash Flow Per Share (Quarterly) | -1.985 |
| Free Cash Flow to Equity (Quarterly) | -294.70M |
| Free Cash Flow to Firm (Quarterly) | -89.59M |
| Free Cash Flow Yield | -6.43% |